AU5681498A - A ctla4-ig fusion protein having high titer - Google Patents
A ctla4-ig fusion protein having high titerInfo
- Publication number
- AU5681498A AU5681498A AU56814/98A AU5681498A AU5681498A AU 5681498 A AU5681498 A AU 5681498A AU 56814/98 A AU56814/98 A AU 56814/98A AU 5681498 A AU5681498 A AU 5681498A AU 5681498 A AU5681498 A AU 5681498A
- Authority
- AU
- Australia
- Prior art keywords
- ctla4
- fusion protein
- high titer
- titer
- fusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108020001507 fusion proteins Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70521—CD28, CD152
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Marine Sciences & Fisheries (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019970001360A KR19980066046A (en) | 1997-01-18 | 1997-01-18 | High-CTLA4-Ig fusion protein |
KR971360 | 1997-01-18 | ||
PCT/KR1998/000009 WO1998031820A1 (en) | 1997-01-18 | 1998-01-19 | A CTLA4-Ig FUSION PROTEIN HAVING HIGH TITER |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5681498A true AU5681498A (en) | 1998-08-07 |
Family
ID=19495004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU56814/98A Abandoned AU5681498A (en) | 1997-01-18 | 1998-01-19 | A ctla4-ig fusion protein having high titer |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR19980066046A (en) |
AU (1) | AU5681498A (en) |
WO (1) | WO1998031820A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6887471B1 (en) | 1991-06-27 | 2005-05-03 | Bristol-Myers Squibb Company | Method to inhibit T cell interactions with soluble B7 |
JP2002522063A (en) * | 1998-08-17 | 2002-07-23 | アブジェニックス インコーポレイテッド | Generation of modified molecules with increased serum half-life |
CA2346996C (en) | 1998-10-23 | 2013-11-19 | Amgen Inc. | Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
US6660843B1 (en) * | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
WO2000064327A2 (en) | 1999-04-26 | 2000-11-02 | Duke University | Inhibition of complement action |
WO2001083525A2 (en) * | 2000-05-03 | 2001-11-08 | Amgen Inc. | Modified peptides, comprising an fc domain, as therapeutic agents |
US7094874B2 (en) | 2000-05-26 | 2006-08-22 | Bristol-Myers Squibb Co. | Soluble CTLA4 mutant molecules |
KR100864120B1 (en) | 2000-07-03 | 2008-10-16 | 브리스톨-마이어스스퀴브컴파니 | Methods for Treating Rheumatic Diseases Using a Soluble CTLA4 Molecule |
US20040022787A1 (en) | 2000-07-03 | 2004-02-05 | Robert Cohen | Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID |
US7754208B2 (en) * | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
PT1397153E (en) | 2001-05-23 | 2008-06-12 | Bristol Myers Squibb Co | Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
KR100453877B1 (en) | 2001-07-26 | 2004-10-20 | 메덱스젠 주식회사 | METHOD OF MANUFACTURING Ig-FUSION PROTEINS BY CONCATAMERIZATION, TNFR/Fc FUSION PROTEINS MANUFACTURED BY THE METHOD, DNA CODING THE PROTEINS, VECTORS INCLUDING THE DNA, AND CELLS TRANSFORMED BY THE VECTOR |
CA2485166A1 (en) | 2002-05-21 | 2003-12-04 | Amgen Inc. | Substituted pyrimidinone and pyridinone compounds |
PL1912675T3 (en) | 2005-07-25 | 2014-10-31 | Emergent Product Dev Seattle | B-cell reduction using cd37-specific and cd20-specific binding molecules |
US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
CN102227447A (en) | 2008-10-02 | 2011-10-26 | 新兴产品开发西雅图有限公司 | Cd86 antagonist multi-target binding proteins |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6090914A (en) * | 1991-06-27 | 2000-07-18 | Bristol-Myers Squibb Company | CTLA4/CD28Ig hybrid fusion proteins and uses thereof |
DE122007000078I2 (en) * | 1991-06-27 | 2011-01-13 | Bristol Myers Squibb Co | CTL4A receptor, fusion proteins containing it and their use |
-
1997
- 1997-01-18 KR KR1019970001360A patent/KR19980066046A/en unknown
-
1998
- 1998-01-19 AU AU56814/98A patent/AU5681498A/en not_active Abandoned
- 1998-01-19 WO PCT/KR1998/000009 patent/WO1998031820A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
KR19980066046A (en) | 1998-10-15 |
WO1998031820A1 (en) | 1998-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU9482098A (en) | Fusion protein systems | |
AU3562299A (en) | Inhibin-hbc fusion protein | |
GB9718609D0 (en) | Fusion protein | |
AU9086798A (en) | Automated packaging | |
AU5065198A (en) | Fusion proteins having increased half-lives | |
AU3827695A (en) | Antigen-binding fusion proteins | |
AU4922497A (en) | Interleukin-18-receptor proteins | |
AU5681498A (en) | A ctla4-ig fusion protein having high titer | |
AU6721696A (en) | Cd44-like protein | |
AU6873596A (en) | Allergen-xcd32 fusion proteins | |
AU9798398A (en) | Gfp-annexin fusion proteins | |
AU7684896A (en) | Fas ligand fusion protein | |
AU9105698A (en) | Rab proteins | |
EP0855029A4 (en) | A high throughput assay using fusion proteins | |
AU1672499A (en) | Proteinase inhibitor fusion proteins | |
AU1999999A (en) | Contryphan peptides | |
AU6000698A (en) | Proteins | |
AUPO957397A0 (en) | Transporter protein | |
AU3645097A (en) | Chondrocyte proteins | |
AU6275098A (en) | Novel h-rev 107-like protein | |
AU5336498A (en) | Barrier | |
AU2136295A (en) | Joining arrangement | |
AU4661697A (en) | Pfs28 fusion proteins | |
AU6834398A (en) | Joint arrangement | |
AU7338298A (en) | Methods for detecting interaction among several proteins |